Space
Connect with Fortrea at BIO to explore ways you can accelerate asset development
03-06 June 2024 San Diego
Join us in San Diego California to participate in the BIO International Convention. This is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.
Join us for a panel discussion with leaders from across the clinical research ecosystem as we explore how to collaborate with providers and Contract Research Organizations (CROs) to accelerate your asset to its next milestone. Incorporating diverse perspectives, this will be an impactful session that will give you insights to take the next step in partnering to access relationships, services, and strategic insights.
Facilitated by Tom Pike, CEO and Chairman of Fortrea, a global CRO that does ~50% of its work with global biotechnology companies, the panelists will discuss evolving trends and best practices regarding how to work with different types of vendors during the clinical development process. Topics include how biotech executives should think about partnering as part of their development strategy, how to leverage partners while building their organization, and lessons learned through their own experiences.
When thinking about how to develop their assets, biotech companies are faced with hundreds of potential partners to choose from. They can benefit from a partner who has solutioned many of the challenges that come with finding, selecting, and contracting with the diverse range of providers required to deliver clinical research. CROs and other providers can act as the "network connector" due to their longstanding relationships with best-in-breed partners, access to innovative technologies and solutions, and their capability to orchestrate the selection and use of these solutions.
View details
Several Fortrea senior executives will be participating in the BIO One-on-One partnering function. We look forward to sitting down with you to explore how our trial experience and industry networks can accelerate the development of your assets resulting in faster, more efficient and patient-centric clinical trials that can deliver higher ROI.
